Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies

This publication has 28 references indexed in Scilit:

• Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues
  Cancer Immunology, Immunotherapy, 2002
• CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia
  Blood, 2002
• Wilms’ Tumor GeneWT1: Its Oncogenic Function and Clinical Application
  International Journal of Hematology, 2001
• Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product
  The Journal of Immunology, 2000
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
  Japanese Journal of Cancer Research, 1999
• Functional diversity of helper T lymphocytes
  Nature, 1996
• Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript
  Human Mutation, 1995
• WT1 -Mediated Growth Suppression of Wilms Tumor Cells Expressing a WT1 Splicing Variant
  Science, 1993
• Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
  Nature, 1990
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
  Cell, 1990